Elon Musk's Neuralink has implanted a chip in a patient's brain that enables control of a computer mouse via thought.

The chip aims to assist those with neurological issues and create a brain-computer interface.

Neuralink's technology has potential applications for restoring mobility, vision, and treating mental health conditions.

Competitors like Clinatec and Synchron are also developing brain-computer interface technologies.

Neuralink's limited information disclosure contrasts with typical scientific community practices.

The company is launching its first human clinical trial targeting individuals with paralysis to test the implant's safety and effectiveness.